Erick Figueiredo Saldanha, MD

My clinical and translational research focuses on early drug development, with respect to experimental therapeutics and phase I clinical trials, with expertise in translating complex first-in-human therapy protocols to the clinic. My disease-specific focus is cutaneous malignancies and melanoma, with robust experience in clinical research spanning early to late phase studies. My special interests include uveal melanoma, rare malignancies, liquid biopsy, and the integration of large-scale omics to personalize cancer care.

Associations

• Cutaneous Oncology

a. uveal melanoma b. rare skin tumors c. genomics, transcriptomics, and liquid biopsy